This inventor holds 1 USPTO granted patent. Top assignee: Biodex. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Alain Meunier: Innovator in Biologically Active Materials
Introduction
Alain Meunier, a prominent inventor based in Saint-Mandé, France, has made a significant contribution to the field of biomaterials. With a focus on innovations that enhance medical applications, his work centers around the development of materials that can effectively aid in the repair of various tissues.
Latest Patents
Meunier holds a patent for a unique biomaterial based on an insolubilized dextran derivative combined with a growth factor. This invention, which is detailed under the title "Biomaterial based on an insolubilized dextran derivative and a growth factor," features a biologically active material that is designed to interact positively with osteoarticular, dental, and maxillofacial tissues. The patent covers not only the composition of this innovative material but also the method of preparing it and its potential applications, including the development of implants and prostheses for these specific medical fields.
Career Highlights
Alain Meunier is affiliated with Biodex, a company that focuses on providing innovative solutions in the healthcare sector. His work at Biodex has been pivotal in advancing the technology of biologically active materials, positioning the company as a leader in medical device development.
Collaborations
Throughout his career, Meunier has collaborated with several noteworthy professionals in his field. Among them are Cinderella Blanchat and Delphine Logeart-Avramoglou, who have contributed to the research and development efforts surrounding his innovations. Their teamwork exemplifies a strong collaborative environment that fosters cutting-edge advancements in biomaterials.
Conclusion
Alain Meunier’s dedication to innovation in the realm of biomaterials not only highlights his inventiveness but also showcases the potential for significant improvements in medical applications. His patent on the biomaterial with an insolubilized dextran derivative represents a promising avenue for future research and development in osteoarticular, dental, and maxillofacial applications. As he continues to push the boundaries of what is possible in medical technology, Meunier's contributions are sure to leave a lasting impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile